These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1689417)

  • 1. ACE inhibition with cilazapril improves myocardial perfusion to the ischemic regions during exercise: a pilot study.
    Gasic S; Dudczak R; Korn A; Kleinbloesem C
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):227-32. PubMed ID: 1689417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ischemic effects of cilazapril in patients with both hypertension and angina pectoris. Preliminary report of a pilot study.
    Schneeweiss A; Marmor AT; Rettig-Stürmer G
    Cardiology; 1991; 79(1):46-8. PubMed ID: 1838032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW
    Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
    Erb KA; Breithaupt K; Kleinbloesem CH; Wolf GK; Belz GG
    Clin Physiol Biochem; 1990; 8 Suppl 2():35-45. PubMed ID: 2151315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril).
    Masuda D; Nohara R; Tamaki N; Hosokawa R; Inada H; Hikai T; Chen LG; Tadamura E; Kudou T; Konishi J; Fujita M; Sasayama S
    Ann Nucl Med; 2000 Oct; 14(5):353-60. PubMed ID: 11108164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
    Ajayi AA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
    Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of cilazapril improves diastolic function in hypertensive patients.
    Marmor A; Green T; Krakuer J; Szucs T; Schneeweiss A
    Am J Med; 1989 Dec; 87(6B):61S-63S. PubMed ID: 2532463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
    Kiowski W; Zuber M; Elsasser S; Erne P; Pfisterer M; Burkart F
    Am Heart J; 1991 Nov; 122(5):1382-8. PubMed ID: 1683143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action.
    Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ
    Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of the new angiotensin-converting enzyme inhibitor cilazapril: a pilot study.
    Mulinari RA; Gouni I; Gavras I; Gavras H
    J Clin Pharmacol; 1988 Jul; 28(7):660-3. PubMed ID: 2975290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new angiotensin converting enzyme inhibitor, cilazapril, on circulating atrial natriuretic factor during exercise in patients with essential hypertension.
    Kohno M; Yasunari K; Murakawa K; Yokokawa K; Horio T; Kurihara N; Takeda T
    J Hypertens Suppl; 1989 Dec; 7(6):S298-9. PubMed ID: 2534417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilazapril in congestive heart failure. A pilot study.
    Kiowski W; Drexler H; Meinertz T; Zuber M; Ritz R; Burkart F; Just H
    Drugs; 1991; 41 Suppl 1():54-61. PubMed ID: 1712273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
    White WB; McCabe EJ; Hager WD; Schulman P
    Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of cilazapril in elderly patients with essential hypertension. A multicenter study.
    Kobrin I; Ben-Ishay D; Bompani R; Dixon R; Hoverman RJ; Jones RW; Kögler P; Sanchez R
    Am J Med; 1989 Dec; 87(6B):33S-36S. PubMed ID: 2532458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.